Compare dividend stocks

JNJ vs PFE

Pfizer, Inc. (PFE) provides a 6.87% dividend yield, notably higher than Johnson & Johnson's (JNJ) 2.12%. JNJ, however, boasts stronger dividend growth with a 29-year streak and a "safe" dividend rating, supported by a lower payout. In contrast, PFE presents a more favorable valuation with a lower P/E and a "fair" margin of safety, differing from JNJ's "expensive" status.

JNJ JN
JNJ
PFE PF
PFE

Key differences

Yield

PFE PF
PFE

6.87%

JNJ 2.12%

CAGR 5y

JNJ JN
JNJ

+5.2%

PFE +3.6%

Safety

JNJ JN
JNJ

Safe

PFE At risk

Dividend score

PFE PF
PFE

7/10

JNJ 4/10

JNJ JN
JNJ Yield Growth Momentum Safety Value Health
4 · Weak Safe
PFE PF
PFE Yield Growth Momentum Safety Value Health
7 · Fair At risk

Price

253.0 USD 25.1 USD

Today

+1.2% -0.4%

Dividend/share

5.4 USD 1.7 USD

2.12% 6.87%

Growth (TTM)

+4.4% +1.2%

CAGR 3y

+4.8% +2.4%

+5.2% +3.6%

29y 16y

Dividend status

Aristocrat (25y+) Contender (10y+)

13.9y 20.1y

Dividend score

4/10 7/10

Safety

Safe At risk
Unlock the full valuation comparison

Chowder number, fair value and Dividend Yield Theory for every stock — plus track them in your portfolio.

The information on Quantic is provided for informational and educational purposes only. It is general in nature, does not take into account your personal financial situation, and does not constitute investment, financial, tax, or legal advice — nor a recommendation to buy or sell any security. Investing involves risk, including possible loss of principal; past performance is not a reliable indicator of future results. Market data comes from third-party providers and may be delayed or inaccurate. Before making any investment decision, consider your objectives, time horizon, risk tolerance, and diversification, and consult a qualified financial professional. Quantic is not a registered investment adviser or broker-dealer.

Built with Elixir, Phoenix LiveView, and Tailwind CSS

© 2026 Francesc Leveque